bromocriptine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camoratto, AM; Grandison, L | 1 |
1 other study(ies) available for bromocriptine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro.
Topics: Animals; Bromocriptine; Cells, Cultured; Dose-Response Relationship, Drug; Growth Hormone; Kinetics; Luteinizing Hormone; Male; Phosphatidylcholines; Pituitary Gland, Anterior; Platelet Activating Factor; Prolactin; Rats; Tetradecanoylphorbol Acetate; Thyrotropin | 1989 |